首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   130篇
  免费   18篇
林业   3篇
农学   2篇
  16篇
综合类   10篇
水产渔业   4篇
畜牧兽医   112篇
植物保护   1篇
  2022年   2篇
  2021年   4篇
  2020年   6篇
  2019年   7篇
  2018年   4篇
  2017年   5篇
  2016年   5篇
  2015年   4篇
  2014年   6篇
  2013年   9篇
  2012年   7篇
  2011年   12篇
  2010年   7篇
  2009年   6篇
  2008年   11篇
  2007年   7篇
  2006年   7篇
  2005年   3篇
  2004年   5篇
  2003年   6篇
  2002年   4篇
  2001年   1篇
  2000年   1篇
  1999年   2篇
  1994年   5篇
  1991年   1篇
  1990年   1篇
  1989年   1篇
  1987年   3篇
  1986年   1篇
  1985年   1篇
  1980年   1篇
  1977年   1篇
  1970年   1篇
  1968年   1篇
排序方式: 共有148条查询结果,搜索用时 15 毫秒
101.
102.
103.
OBJECTIVE: To determine whether oral administration of L-lysine to cats would lessen the severity of conjunctivitis caused by feline herpesvirus (FHV-1). ANIMALS: 8 healthy young adult cats. PROCEDURE: Cats received oral administration of lysine monohydrochloride (500 mg, q 12 h) or placebo (lactose) beginning 6 hours prior to inoculation of virus. The left conjunctival sac received a 50-microl suspension of FHV-1 grown in cell culture (1.8 X 10(8) tissue culture infective dose50) on day 1. Cats were evaluated and scores given for clinical signs each day for 21 days. Samples for virus isolation were collected from the eye and throat every third day. Plasma lysine and arginine concentrations were measured prior to the study and on days 3, 14, and 22. RESULTS: Cats that received lysine had less severe conjunctivitis than cats that received placebo. Virus isolation results did not differ between the groups. Plasma lysine concentration was significantly higher in cats that received lysine, compared with control cats, whereas plasma arginine concentrations did not differ between groups. CONCLUSIONS AND CLINICAL RELEVANCE: Oral administration of 500 mg of lysine to cats was well tolerated and resulted in less severe manifestations of conjunctivitis caused by FHV-1, compared with cats that received placebo. Oral administration of lysine may be helpful in early treatment for FHV-1 infection by lessening the severity of disease.  相似文献   
104.
105.
106.
107.
Plasma luteinising hormone (LH) concentrations were measured during the ovulatory cycle in lines of Australorps and White Leghorns selected for reduced oviposition interval and maintained under continuous light and noise.

2. Selection significantly increased plasma LH concentrations in mid‐sequence ovulatory cycles of Australorps but not in the White Leg‐horns.

3. Selection in the Australorps apparently increased the rate of ovarian follicular maturation, resulting in more frequent LH peaks.

4. The effect of selection on plasma LH concentrations is a function of the lighting condition to which the hens are exposed.  相似文献   

108.
1. Effects of food restriction on growth rate and relative growth rates of supply organs (liver, heart, lungs and kidneys, digestive tract) and demand organs (breast, back, thighs, abdominal fat) of broiler chickens were studied.

2. Birds were restricted in intake to 50% (group FI 50) or 75% (group FI 75) of ad libitum from 5 to 11 d of age; all birds were fed ad libitum from 12 to 39 d of age.

3. Relative growth rates from 12 to 39 d of age of group FI 50 were higher (P<0.05) than group FI 75 and control group.

4. No significant differences in food conversion ratio, carcase fat and abdominal fat between groups were observed.

5. At 12 d of age, relative weight of the empty digestive tract of group FI 50 was higher (P< 0.05) than that of the control group and group FI 75.

6. The increased weight of the empty digestive tract may have contributed to the ability of the chickens to achieve compensatory growth after the restriction period.  相似文献   

109.
Hyperammonaemia is a common complication of liver disease in dogs. High concentrations of ammonia can be detrimental to dogs with liver disease for several reasons, notably by causing hepatic encephalopathy (HE) which describes the wide range of neurological abnormalities ranging from altered behaviour to seizures that are well recognised complications in dogs with hepatic disorders. In human patients with liver disease, hyperammonaemia has also been linked to the development of other systemic complications such as dysregulation of the innate immune system. In contrast, the effects of hyperammonaemia on the canine innate immune system is currently unknown. The aim of this study was to investigate the effects of ammonia on the oxidative burst activity of canine polymorphonuclear cells in vitro. Blood obtained from healthy dogs (n?=?8) was incubated with escalating concentrations of ammonia ranging from 0 to 250 μM, and the percentage of cells experiencing an oxidative burst was evaluated using a commercial kit (Phagoburst?) and flow cytometry. The spontaneous oxidative burst was evaluated without stimulation and also following stimulation with E coli. The pH of the blood was also measured at the differing ammonia concentrations. There was an increase in the percentage of cells experiencing a spontaneous oxidative burst from ammonia concentrations of 125 μM (p?=?<0.05) and above (p?=?<0.01), with a 4.9 fold increase at 200 μM (p?=?< 0.001). In those cells stimulated with E coli, incubation with increasing ammonia concentrations did not result in a significant difference in oxidative burst from baseline (p?=?0.953). There was no statistically significant difference between the pH of the blood at the various ammonia concentrations (p?=?0.2) suggesting that the difference in spontaneous oxidative burst was due to the ammonia rather than simply a change in pH conditions. In summary, the spontaneous oxidative burst of neutrophils was significantly increased from baseline. This supports a potential role of ammonia in contributing to innate immune system dysfunction in dogs with liver disease, and may present a future therapeutic target.  相似文献   
110.
OBJECTIVE: To evaluate the success of the use of systemic corticosteroids and antifungal medications in the treatment of dogs with ocular lesions associated with systemic blastomycosis. DESIGN: Retrospective study. ANIMALS STUDIED: Medical records of 25 dogs diagnosed with blastomycosis, via either cytology or histopathology, at the Purdue University Veterinary Teaching Hospital between 1 January 2000 and 1 January 2005, were reviewed. PROCEDURE: Data collected from the medical records included signalment, presence and progression of ocular lesions, antifungal drugs administered, oral and topical corticosteroid administration, length of follow-up, response to treatment, and visual outcome. RESULTS: Of the 25 cases reviewed, 12 dogs (19 eyes) with follow-up information were found to have lesions consistent with ocular blastomycosis. Length of follow-up in the 12 cases ranged from 1 month to 31 months with a mean of 9 months. Antifungal therapy for all cases consisted of oral itraconazole (5 mg/kg every 24 h) initially. In seven cases, the antifungal drug administered was changed from itraconazole to oral fluconazole. Two of these also received intravenous amphotericin B, and two received additional treatment with itraconazole. All 12 dogs also received oral prednisone. The dose of oral prednisone utilized ranged from 0.2 mg/kg/day to 1.4 mg/kg/day with a mean of 0.7 mg/kg/day; the duration of oral prednisone administration ranged from 2 weeks to 8.5 months with a mean of 3 months. Topical prednisolone was a component of the treatment of 16 of the 19 eyes. Duration of topical prednisolone treatment ranged from 1 month to 30 months with a mean of 5 months. Lesions not located in the eyes exhibited a positive response to treatment in 11 (92%) of the 12 dogs. Overall, 14/19 (74%) affected eyes were visual at the time of their final recheck. All eyes with mild or moderate lesions and 5/10 (50%) severely affected eyes were visual at their last recorded recheck examination. CONCLUSIONS: The administration of systemic corticosteroids did not appear to adversely affect the survival rate and might have played a role in preservation of vision in a majority of dogs in this group with ocular blastomycosis.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号